HomeENVB • NASDAQ
add
Enveric Biosciences Inc
Previous close
$0.99
Day range
$0.95 - $1.00
Year range
$0.86 - $8.32
Market cap
3.16M USD
Avg Volume
245.79K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.52M | 32.73% |
Net income | -2.52M | -34.04% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.48M | -36.73% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.85M | -18.64% |
Total assets | 3.55M | -41.36% |
Total liabilities | 1.36M | 111.31% |
Total equity | 2.18M | — |
Shares outstanding | 3.25M | — |
Price to book | 1.38 | — |
Return on assets | -145.60% | — |
Return on capital | -203.07% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -2.52M | -34.04% |
Cash from operations | -1.89M | 34.58% |
Cash from investing | — | — |
Cash from financing | 449.10K | 1,204.37% |
Net change in cash | -1.44M | 49.37% |
Free cash flow | -1.17M | 55.14% |
About
Founded
1994
Headquarters
Website
Employees
6
